Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study

Published:2022-06-24 Issue: Volume: Page:1-9
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Nakai Shunsaku¹,Takeuchi Masaru¹,Usui Yoshihiko²,Namba Kenichi³,Suzuki Kayo³,Harada Yosuke⁴,Kusuhara Sentaro⁵,Kaburaki Toshikatsu⁶,Tanaka Rie⁷,Takeuchi Masaki⁸,Mizuki Nobuhisa⁸,Nakai Kei⁹,Goto Hiroshi²,Herbort Carl P.¹⁰¹¹

Affiliation:

1. Department of Ophthalmology, National Defense Medical College, Saitama, Japan

2. Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan

3. Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

4. Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University, Higashihiroshima, Japan

5. Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan

6. Department of Ophthalmology, Jichi Medical University Saitama Medical Center, Saitama, Japan

7. Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan

8. Department of Ophthalmology and Visual Science, Graduate School of Medicine, Yokohama City University, Yokohama, Japan

9. Department of Ophthalmology, Yodogawa Christian Hospital, Osaka, Japan

10. Centre for Ophthalmic Specialized Care, Lausanne, Switzerland

11. Jichi Medical University Saitama Medical Center, Saitama, Japan

Funder

Grants-in-Aid for Scientific Research C

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2022.2092007

Reference48 articles.

1. Vogt-Koyanagi-Harada Syndrome

2. Vogt-Koyanagi-Harada disease

3. Catching the therapeutic window of opportunity in early initial-onset Vogt–Koyanagi–Harada uveitis can cure the disease

4. Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt–Koyanagi–Harada disease: an updated review

5. Pathogenesis of Vogt-Koyanagi-Harada Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease;BMC Ophthalmology;2024-06-07

2. Clinical and Transcriptional Profiles Reveal the Treatment Effect of Adalimumab in Patients with Initial-Onset and Recurrent Vogt–Koyanagi–Harada Disease;Ocular Immunology and Inflammation;2024-05-06

3. Vogt-Koyanagi-Harada Disease;Ocular Immunology and Inflammation;2024-04-20

4. Bibliometric analysis of the Vogt‒Koyanagi‒Harada disease literature;International Ophthalmology;2023-08-08

5. A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease;Nature Communications;2023-06-24